InvestorsObserver
×
News Home

Insmed Incorporated (INSM) has risen 10.61% in a Week, Should You Buy?

Thursday, August 04, 2022 02:47 PM | InvestorsObserver Analysts

Mentioned in this article

Insmed Incorporated (INSM) has risen 10.61% in a Week, Should You Buy?

A rating of 95 puts Insmed Incorporated (INSM) near the top of the Biotechnology industry according to InvestorsObserver. Insmed Incorporated's score of 95 means it scores higher than 95% of stocks in the industry. Insmed Incorporated also received an overall rating of 84, putting it above 84% of all stocks. Biotechnology is ranked 24 out of the 148 industries.

Overall Score - 84
INSM has an Overall Score of 84. Find out what this means to you and get the rest of the rankings on INSM!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 84 would rank higher than 84 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Insmed Incorporated Stock Today?

Insmed Incorporated (INSM) stock is up 14.5% while the S&P 500 is lower by -0.06% as of 2:46 PM on Thursday, Aug 4. INSM is higher by $3.16 from the previous closing price of $21.76 on volume of 1,568,673 shares. Over the past year the S&P 500 is lower by -5.68% while INSM is higher by 0.61%. INSM lost -$3.78 per share the over the last 12 months. Click Here to get the full Stock Report for Insmed Incorporated stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App